News & Events
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
03 / 06 / 2014
Celladon Corporation Appoints Paul Cleveland as President and Chief Financial Officer
03 / 06 / 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
27 / 05 / 2014
Sunshine Heart Announces Presentations at the Annual Meeting of the Heart Failure Association
14 / 05 / 2014
PLC Systems Proposes Series of Business Transactions Designed to Preserve Value for Shareholders
14 / 05 / 2014
FDA Approves Teva SYNRIBO® (Omacetaxine Mepesuccinate) for Injection for Home Administration
07 / 05 / 2014
Sunshine Heart Announces Presentations at 2014 International Society for Heart and Lung
03 / 04 / 2014
Spinifex PhII Results Show EMA401 to be Effective in Reducing Pain in Postherpetic Neuralgia
20 / 03 / 2014
Celladon Corporation Announces Appointments of Dr. Peter Honig and Dr. Patrick Yang to Its Board
03 / 03 / 2014
Celladon Announces Exercise in Full and Closing of Underwriters' Option to Purchase Additional Shares
27 / 02 / 2014
Teva Announces Full FDA Approval of SYNRIBO® (Omacetaxine Mepesuccinate) for Injection
17 / 02 / 2014
Study on Ventilator-Associated Pneumonia Incidence Reported at Critical Care Congress
13 / 01 / 2014
Displaying records 26-50 of 53